Sat.Mar 15, 2025 - Fri.Mar 21, 2025

article thumbnail

Diclofenac vs. naproxen: Differences & similarities explained

The Checkup by Singlecare

For many people with pain or inflammation, healthcare providers often prescribe medications like diclofenac or naproxen. These drugs belong to a group called nonsteroidal anti-inflammatory drugs (NSAIDs). Diclofenac and naproxen may help reduce inflammation and relieve pain caused by conditions like arthritis, menstrual cramps, or migraines. While both medications can help people relieve pain and discomfort that interferes with daily activities, they may differ in various ways.

article thumbnail

Which Social Media Analytics Matter Most in Pharma Marketing

Pharma Marketing Network

Introduction Social media has become an essential tool for pharmaceutical marketing. However, simply posting content is not enough. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. But which metrics truly matter? With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The future of clinical pharmacy in Europe with ESCP president Monika Lutters

Hospital Pharmacy Europe

In an era of rapid healthcare evolution, clinical pharmacy is at a crossroads in Europe, facing both unprecedented opportunities and pressing challenges, and Dr Monika Lutters, ESCP president, is at the forefront of these developments. Here, speaking to Gerry Hughes, she shares her insights on current clinical pharmacy challenges around expansion and integration of hospital pharmacists, and the exciting trajectory this branch of pharmacy is set to undertake in the years ahead.

article thumbnail

Private equity ‘gobbling’ up care facilities for people with disabilities

STAT

Private equity firms are acquiring facilities that care for people with intellectual or developmental disabilities at an alarming rate, according to a new report released Tuesday. The care industry for this population has been historically owned and operated by nonprofits and faith-based institutions. However, between 2013 and 2023, private equity firms made over 1,000 acquisitions of disability and elder care providers — a likely undercount, according to the report published by the Priva

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

7 health benefits of raspberry leaf tea

The Checkup by Singlecare

Raspberries are vibrant, juicy, and somewhat tart berries known for their rich fiber and antioxidant content. The berries are plucked and enjoyed as a healthy snack or topping on oatmeal and yogurt. But did you know that the leaves of the raspberry plant ( Rubus idaeus ) may have health benefits, too? You may have heard of red raspberry leaf tea. It is a caffeine-free herbal tea made from the dried leaves of the fruit-bearing plant.

article thumbnail

Audience Engagement Strategies for Pharma Marketing: Boost HCP and Patient Interaction

Pharma Marketing Network

Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation.

More Trending

article thumbnail

STAT+: Congress created a unique plan to save rural hospitals — but few are using it

STAT

When Ted Matthews came out of retirement in early 2023 to retake the helm of the rural Texas hospital where he’d started his health care career, it was something of a rescue mission. They were having bake sales to keep the place afloat. Staff were updating their resumes. At every board meeting, they’d decide which bills to pay.  “It was the consensus that we were going to be that twenty-seventh rural hospital in Texas to close,” said Matthews, interim CEO of Anso

article thumbnail

Tirzepatide vs. semaglutide: Differences & similarities explained

The Checkup by Singlecare

Tirzepatide and semaglutide have exploded in popularity over the past few years, primarily due to their weight loss benefits. Tirzepatide is the active ingredient in both Mounjaro and Zepbound , while semaglutide is the active ingredient in Ozempic , Wegovy , and Rybelsus (an oral medicine). These medications act like natural hormones in the body, regulating appetite and reducing food noise (intrusive thoughts about food that interfere with weight loss efforts).

article thumbnail

First cardiology consultant pharmacist appointed in Scotland to improve patient outcomes

Hospital Pharmacy Europe

Scotlands first cardiology consultant pharmacist has been appointed by NHS Golden Jubilee to provide professional leadership and mentorship and improve patient outcomes across the region. Paul Forsyth, who has 20 years experience working with cardiac patients, most recently as a heart failure pharmacist and lead pharmacist in clinical cardiology (primary care) at NHS Greater Glasgow and Clyde, will work across organisational boundaries to support cardiology lead pharmacists in the west of Scotla

article thumbnail

Are you moving to more of an omnichannel marketing approach?

Pharma Marketing Network

Introduction In todays competitive pharmaceutical landscape, marketing strategies must evolve to meet changing customer expectations. Are you still relying on traditional marketing tactics, or have you embraced a more dynamic, omnichannel marketing approach? With healthcare providers (HCPs) and patients engaging across multiple digital and offline touchpoints, pharma brands that fail to adapt risk losing valuable market share.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Opinion: How to protect the American egg supply from avian flu  

STAT

Wholesale egg prices have dropped by more than 40% since late February, a decline that should soon translate into broader savings for consumers at grocery stores. This welcome respite has largely resulted from the lull in significant bird flu outbreaks in recent weeks, perhaps due to seasonal patterns in the virus’s transmission. North American flyways typically remain quiet in February as migratory birds have yet to start their journeys from their winter habitats.

article thumbnail

Eliquis vs. aspirin: Differences & similarities explained

The Checkup by Singlecare

Eliquis (apixaban) and aspirin are both oral drugs that decrease blood clotting, but that is where their similarities end. They thin the blood by very different mechanisms and are used for different medical conditions. How effective one is versus the other depends on the condition being treated. And their side effects and costs are quite different. Well compare and contrast Eliquis and aspirin so you better understand why your healthcare provider may recommend one over the other.

article thumbnail

The Issue with Reissue: PTE Edition

The FDA Law Blog

By Sara W. Koblitz Integral to the careful balance Congress struck when passing the Hatch-Waxman Amendments, the patent term extension (PTE) is intended to restore patent life that was consumed during regulatory review of an FDA-regulated product. Even though the PTE provisions established in the Drug Price Competition and Patent Restoration Act are forty-plus years old, courts are still grappling with questions about how to best implement the Patent Term Extension.

article thumbnail

Patient Education When Initiating Treatment for Menopausal Symptoms

Pharmacy Times

Panelists note how medical professionals discuss menopause therapy, addressing symptoms, treatment options, safety concerns, adverse events, and personalized management strategies through patient-centered care. Professionals prioritize transparent communication, comprehensive risk assessment, and collaborative decision-making to ensure patient comfort and optimal management of menopausal transition.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Former CDC director Tom Frieden shares warning for RFK Jr. on measles outbreak

STAT

NEW YORK —   A former top federal health official is publicly warning Robert F. Kennedy Jr. that wavering on vaccines and slashing federal programs during a deadly measles outbreak could unleash the next public health disaster.  “The federal government might pause, but the measles virus doesn’t pause. Bacteria and viruses don’t pause.

article thumbnail

Cyclobenzaprine vs. baclofen: Differences & similarities explained

The Checkup by Singlecare

Muscle spasms and stiffness can be painful and uncomfortable, with healthcare providers often prescribing medications like cyclobenzaprine or baclofen to help. These drugs are muscle relaxants used to relieve spasms from musculoskeletal conditions, nerve problems, or spinal cord injuries. They help relax muscles and reduce pain, providing people with much-needed relief.

article thumbnail

Why Healthcare is Seeing an Increase in 2025 Ad Budgeting

Pharma Marketing Network

Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.

article thumbnail

Novo Nordisk industry membership reinstated

European Pharmaceutical Review

Novo Nordisk has regained full membership with the Association of the British Pharmaceutical Industry (ABPI), following suspension in 2023. This action resulted after the pharmaceutical company made serious breaches of the ABPI Code of Practice in 2021. The case was the eighth instance in the past four decades that the ABPIs board has issued this degree of sanction, the industry body highlighted upon announcing the news.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Tapping the potential of GLP-1 drugs requires integrated care and overcoming inequities, executives say

STAT

The GLP-1 class of drugs used to treat diabetes and obesity may have the potential to benefit huge swaths of the public, but ongoing employer concerns over cost and a lack of patient adherence remain stubborn obstacles to wider adoption, a pair of health executives explained Thursday. The medicines have proven wildly popular and, in turn, have generated huge sales, long stretches of shortages, and unchecked excitement among investors.

article thumbnail

Can you take semaglutide with tirzepatide?

The Checkup by Singlecare

Semaglutide and tirzepatidethese drugs are all the rage right now. You may know people who have had great success using one of these drugs for weight loss, and you may think, if one weight loss drug is so beneficial, should I try both at the same time? Is a tirzepatide semaglutide combination right for me? Unfortunately, these drugs are not meant to be combined.

article thumbnail

Pharma Ad Retargeting Basics

Pharma Marketing Network

Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. Ad retargeting has become a powerful tool for pharma marketers, enabling brands to re-engage potential customers who have shown interest but have not yet converted. But how does ad retargeting work in pharma marketing, and what strategies yield the best results?

article thumbnail

A closer look at how health care consolidation drives up patient costs, creates barriers to care

PhRMA

Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program. As entities in the supply chain that don’t make medicine are increasingly using medicines to subsidize other parts of their business, patients and employers face increasing costs and barriers to accessing c

article thumbnail

STAT+: Device maker Zynex Medical under pressure from insurers, SEC filings show

STAT

TriCare, the federal health insurer for the military, has temporarily stopped paying the medical claims of pain management device maker Zynex Medical.  In a recent filing with the Securities and Exchange Commission, Zynex revealed that the government payer — which represents up to a quarter of Zynex’s annual revenue — was suspending payments as it reviewed prior claims.

article thumbnail

Why take Zyrtec and Pepcid together?

The Checkup by Singlecare

There are several reasons one may consider taking Zyrtec and Pepcid together. They both block histamine receptors, but their mechanisms are different enough to have additive benefits. Zyrtec (cetirizine) is an antihistamine used for allergies , while Pepcid (famotidine) blocks gastric histamine-2 (H2) receptors and thereby decreases stomach acid production in the treatment of gastroesophageal reflux disease (GERD) and stomach ulcers.

article thumbnail

How to use Pay Per Click Advertising to Reach HCPs in Pharma

Pharma Marketing Network

Introduction Reaching healthcare professionals (HCPs) in the pharmaceutical industry has become increasingly challenging due to strict regulations, evolving digital landscapes, and the growing demand for personalized content. However, pay per click advertising (PPC) presents a powerful and targeted solution for pharma marketers looking to engage HCPs efficiently.

article thumbnail

Albanese says PBS ‘not up for negotiation’ after US pharma complains to Trump about scheme

The Guardian - Pharmaceutical Industry

Labor and Coalition shoot back at criticism, with the PM saying subsidies on medicine isnt about delivering for big pharma Follow our Australia news live blog for latest updates Get our breaking news email , free app or daily news podcast Australias successful scheme for heavily subsidising the price of vital medicines is not up for negotiation as part of new American tariff threats, Anthony Albanese says, after US pharmaceutical companies complained to Donald Trump about how it damaged their pr

article thumbnail

Blood test for ovarian cancer misses some Black and Native American patients, study finds

STAT

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of  medical tests  that contribute to  health care disparities. Researchers have been working to uncover these kinds of biases in medicine. Recently, the Trump administration’s crackdown on diversity, equity and inclusion has  jeopardized such research  as universities react to political pressure and fe

article thumbnail

The expanding use of GLP-1s

The Checkup by Singlecare

GLP-1 receptor agonists have greatly changed how we treat diabetes and obesity in recent years. Popular medications like Ozempic , Wegovy , and Zepbound have become popular not only for their ability to manage blood sugar levels but also for their impressive weight loss benefits. Beyond diabetes and weight loss, the use of GLP-1 medications is expanding into treatment for kidney disease, peripheral neuropathy, and potentially even dementia.

FDA
article thumbnail

European Pharmaceutical Review Issue 1 2025

European Pharmaceutical Review

Included in Issue 1 of European Pharmaceutical Review : FOREWORD AI in pharmaceutical development: hype or panacea? David Elder, David P Elder Consultancy IN-DEPTH FOCUS: MANUFACTURING AI-driven biomanufacturing: revolutionising production and quality in pharmaceuticals Ian Betteridge , European Pharmaceutical Review Regulating decentralised manufacturing in the UK – a legal perspective Harry Jennings, VWV law Advancing environmental monitoring systems for CGT manufacturing Gill Lewis, eXm

article thumbnail

Student Research Opportunities

Blog: Ask a Student Pharmacist

Student Research Opportunities eomizowh Mon, 03/17/2025 - 13:52 Directed Study / Research Under the direction of a faculty member, students may earn Directed Research or Directed Study credits for special projects. Directed Study at the College of Pharmacy follows University of Minnesota policy , which generally requires an average workload of three hours per week per academic credit.

article thumbnail

STAT+: Teenager who received Elevidys, Sarepta’s Duchenne gene therapy, dies 

STAT

Sarepta Therapeutics said Tuesday that a 16-year-old boy died after receiving Elevidys, its gene therapy for Duchenne muscular dystrophy, the first known death linked to the treatment. The teenager suffered liver failure, a side effect that has been seen with other gene therapy treatments over the last two decades.  Sarepta said in its statement that a recent cytomegalovirus infection could have also contributed to the patient’s death, putting him at heightened risk.

article thumbnail

Do Paid Social Media Campaigns work?

Pharma Marketing Network

Table of Contents Understanding Paid Social Media Campaigns in Pharma Marketing Key Benefits of Paid Social Media Advertising for Pharma Brands Best Practices for Optimizing Paid Social Media Campaigns Measuring Success: How to Track ROI and Engagement Understanding Paid Social Media Campaigns in Pharma Marketing Pharmaceutical marketing has evolved significantly with the rise of paid social media campaigns , enabling brands to reach healthcare professionals (HCPs), patients, and caregivers in w

article thumbnail

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

The Guardian - Pharmaceutical Industry

Pharmaceutical company will invest money over five years in strategic partnership with the citys authorities Business live latest updates AstraZeneca will invest $2.5bn in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and the detentions of top executives in China.